We saw few surprises in Quest Diagnostics ' first-quarter results, and we ..... leverage to kick in. We have also left Quest 's narrow moat intact. Even as ..... reference lab market have improved, Quest continues to trail behind LabCorp
NEW YORK, April 21 (Reuters) - Quest Diagnostics Inc , the world's largest provider of diagnostic testing services, is working with France's national health agency to build an
Quintiles and Quest Diagnostics announced an agreement on March 31 to form a ..... leaving our fair value estimates for Quintiles and Quest unchanged. Quintiles will own 60% and Quest Diagnostics 40% of the joint venture, and management claims
March 31 (Reuters) - Medical tests maker Quest Diagnostics Inc and contract research company Quintiles Transnational Holdings Inc said they were combining their clinical trial laboratory operations...
On March 31, Quintiles and Quest Diagnostics announced an agreement to form a joint ..... fair value estimates for Quintiles and Quest unchanged. Quintiles will own 60% and Quest Diagnostics 40% of the joint venture; management
March 31 (Reuters) - Medical tests maker Quest Diagnostics Inc and contract research company Quintiles said they were combining their clinical trial laboratory operations in a joint venture.
Quest Diagnostics posted respectable fourth-quarter results ..... liked the structural characteristics of Quest 's narrow moat and anticipate these will ..... Affordable Care Act. Unfortunately, Quest 's improved volume did not translate
for the combined company. However, we believe the combined entity will enjoy competitive benefits over key rival Quest Diagnostics , especially over the longer term as the new post-health-care-reform world evolves. We think the strategic
Quest Diagnostics posted respectable third-quarter results ..... suggest volume and pricing are improving for Quest . We stand behind the firm's narrow ..... the moat trend is stable. We applaud Quest 's decision to walk away from unprofitable
Quest Diagnostics released second-quarter performance ..... organic volume growth remains lackluster at Quest . On one hand, quarterly organic volume ..... quarters of declines. On the other hand, Quest continues to trail its main rival LabCorp